Maarten Overkamp

Maarten Overkamp

Auto-generated profile, based on publicly available information

Maarten Overkamp

Department of Human Biology NUTRIM School of Nutrition and Translational Research in Metabolism Maastricht University Medical Center + Maastricht The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Scandinavian Journal of Urology
Verified
Journal Article
Open access
MOMaarten Overkamp
Maarten Overkamp
LHLisanne H. P. Houben
Lisanne H. P. Houben
SMSaskia van der Meer
Saskia van der Meer
JRJoep G. H. van Roermund
Joep G. H. van Roermund
RBRonald Bos
Ronald Bos
SBSandra Beijer
Sandra Beijer
To assess the adverse impact of the first 5 months of androgen deprivation therapy on body composition, physical performance, cardiometabolic health and health-related quality-of-life in prostate c...

10 May 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MOMaarten Overkamp
Maarten Overkamp
LHLisanne H P Houben
Lisanne H P Houben
TAThorben Aussieker
Thorben Aussieker
JKJanneau M X van Kranenburg
Janneau M X van Kranenburg
PPPhilippe J M Pinckaers
Philippe J M Pinckaers
TSTim Snijders
Tim Snijders
Context Androgen deprivation therapy (ADT) forms the cornerstone in prostate cancer (PCa) treatment. However, ADT also lowers skeletal muscle mass. Objective To identify the impact of ADT with and without resistance exercise training on muscle fiber characteristics in PCa patients. Methods Twenty-one PCa patients (72 ± 6 years) starting ADT were included. Tissue samples from the vastus lateralis muscle were assessed at baseline and after 20 weeks of usual care (n = 11) or resistance exercise training (n = 10). Type I and II muscle fiber distribution, fiber size, and myonuclear and capillary contents were determined by immunohistochemistry. Results Significant decreases in type I (from 7401 ± 1183 to 6489 ± 1293 μm2, P < .05) and type II (from 6225 ± 1503 to 5014 ± 714 μm2, P < .05) muscle fiber size were observed in the usual care group. In addition, type I and type II individual capillary-to-fiber ratio (C/Fi) declined (−12% ± 12% and −20% ± 21%, respectively, P < .05). In contrast, significant increases in type I (from 6700 ± 1464 to 7772 ± 1319 μm2, P < .05) and type II (from 5248 ± 892 to 6302 ± 1385 μm2, P < .05) muscle fiber size were observed in the training group, accompanied by an increase in type I and type II muscle fiber myonuclear contents (+24% ± 33% and +21% ± 23%, respectively, P < .05) and type I C/Fi (+18% ± 14%, P < .05). Conclusion The onset of ADT is followed by a decline in both type I and type II muscle fiber size and capillarization in PCa patients. Resistance exercise training offsets the negative impact of ADT and increases type I and II muscle fiber size and type I muscle fiber capillarization in these patients.

30 January 2024 in European Journal of Sport Science
Verified
Journal Article
Open access
LHLisanne H. P. Houben
Lisanne H. P. Houben
MOMaarten Overkamp
Maarten Overkamp
JSJoan M. G. Senden
Joan M. G. Senden
JRJoep G. H. van Roermund
Joep G. H. van Roermund
PVPeter de Vries
Peter de Vries
SBSandra Beijer
Sandra Beijer
Resistance exercise training is effective to counteract the adverse effects of androgen deprivation therapy (ADT) on body composition, muscle mass and leg strength in prostate cancer patients (PCa). However, it is unknown whether these effects can be autonomously maintained after cessation of the supervised program. Sixty‐eight PCa patients on ADT were included. The exercise intervention group (EX, n = 37) performed 20 weeks of supervised resistance exercise training. Thereafter, patients were advised to autonomously continue exercise training. The control group (CON, n = 31) only received usual care. Outcome measures were compared between baseline and after 1 year. Changes during the intervention (baseline vs. 20 weeks) and follow‐up period (20 weeks vs. 1 year) were descriptively explored. In EX, 83% reported to have continued exercise training themselves. After 1 year, fat mass gains were attenuated in EX compared to CON (1.2 ± 2.6 and 2.8 ± 1.9 kg, respectively; time × treatment effect p = 0.032). The fat percentage increased, and lean mass and quadriceps muscle cross‐sectional area decreased over time, with no differences between groups (overall 1.6 ± 2.1%, −0.7 ± 2.3 kg and −2.2 ± 2.9 cm2, respectively; time effects, all p < 0.05). For muscle strength, an increase of ∼5% in EX was observed, significantly different from the ∼10% decrease in CON (p < 0.001). Subsequent analyses showed that the initial exercise training‐obtained gains in lean mass, muscle mass and strength in EX compared to CON, declined during the follow‐up period. In conclusion, PCa patients on ADT are not capable to autonomously maintain the exercise‐obtained gains of a 20‐week supervised training program over a subsequent 1‐year period.